PT1392285E - Medicamento contendo um efector do metabolismo da glutationa em conjunto com acido alfa-lipoico no ambito da terapia de substituicao renal - Google Patents

Medicamento contendo um efector do metabolismo da glutationa em conjunto com acido alfa-lipoico no ambito da terapia de substituicao renal

Info

Publication number
PT1392285E
PT1392285E PT02747189T PT02747189T PT1392285E PT 1392285 E PT1392285 E PT 1392285E PT 02747189 T PT02747189 T PT 02747189T PT 02747189 T PT02747189 T PT 02747189T PT 1392285 E PT1392285 E PT 1392285E
Authority
PT
Portugal
Prior art keywords
glutathetic
effector
metabolism
alpha
conjunction
Prior art date
Application number
PT02747189T
Other languages
English (en)
Inventor
Dieter Koegst
Gerhard Fries
Siegfried Ansorge
Taeger Michael
Original Assignee
Serumwerk Bernburg Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serumwerk Bernburg Ag filed Critical Serumwerk Bernburg Ag
Publication of PT1392285E publication Critical patent/PT1392285E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT02747189T 2001-05-28 2002-05-24 Medicamento contendo um efector do metabolismo da glutationa em conjunto com acido alfa-lipoico no ambito da terapia de substituicao renal PT1392285E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10125883A DE10125883A1 (de) 2001-05-28 2001-05-28 Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie

Publications (1)

Publication Number Publication Date
PT1392285E true PT1392285E (pt) 2005-06-30

Family

ID=7686362

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02747189T PT1392285E (pt) 2001-05-28 2002-05-24 Medicamento contendo um efector do metabolismo da glutationa em conjunto com acido alfa-lipoico no ambito da terapia de substituicao renal

Country Status (17)

Country Link
US (1) US7531567B2 (pt)
EP (1) EP1392285B1 (pt)
JP (1) JP4245926B2 (pt)
CN (1) CN100435793C (pt)
AR (1) AR034336A1 (pt)
AT (1) ATE288750T1 (pt)
BR (1) BR0209732A (pt)
CA (1) CA2446673C (pt)
DE (3) DE10125883A1 (pt)
DK (1) DK1392285T3 (pt)
ES (1) ES2237683T3 (pt)
HK (1) HK1063606A1 (pt)
MX (1) MXPA03010833A (pt)
PE (1) PE20030090A1 (pt)
PT (1) PT1392285E (pt)
RU (1) RU2285525C2 (pt)
WO (1) WO2002096414A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125882B4 (de) * 2001-05-28 2007-03-29 Esparma Gmbh Arzneimittel enthaltend Ambroxol, dessen Salze und/oder Prodrugs zusammen mit α-Liponsäure im Rahmen der Behandlung des Diabetes mellitus
DE10258239A1 (de) * 2002-12-13 2004-06-24 Degussa Ag Formulierung enthaltend alpha-Liponsäure(-Derivate) als alleinigen Wirkstoff bei nichtchronischen alkoholinduzierten Intoxikationen
DE10303229B4 (de) 2003-01-28 2007-07-26 Keyneurotek Ag Ambroxol und Inhibitoren des Angiotensin Converting-Enzyms (ACE) umfassende Arzneimittel Arzneimittel-Zubereitung und ihre Verwendung zur Behandlung von neurodegenerativen Erkrankungen
DE10360954B3 (de) * 2003-12-23 2005-08-18 Esparma Gmbh Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen
RU2394561C2 (ru) * 2004-11-24 2010-07-20 Хилл`С Пет Ньютришн, Инк. Способы увеличения иммунного ответа у животного
DK2638915T3 (en) 2008-07-18 2017-01-30 A1M Pharma Ab MEDICAL USE OF THE RADICAL BINDER AND ANTIOXIDANT ALFA-1 MICROGLOBULIN
US20100173936A1 (en) * 2008-12-01 2010-07-08 Khan Bobby V Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system-related disorders
RU2530601C2 (ru) * 2012-10-05 2014-10-10 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Ингибитор образования цинк-зависимых димеров бета-амилоида
CN106955270B (zh) * 2017-04-14 2018-04-27 黑龙江中桂制药有限公司 一种盐酸氨溴索口服溶液及其制备方法与新用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3530761A1 (de) 1985-08-28 1987-03-05 Klinge Co Chem Pharm Fab Arzneimittelkombination mit synergistischer wirkung
DE3804858A1 (de) * 1988-02-17 1989-08-31 Thomae Gmbh Dr K Mittel gegen hyperurikaemie
IE904034A1 (en) * 1989-11-09 1991-05-22 Asta Medica Ag A medicament containing r-ó-lipoic acid or s-ó-lipoic acid¹as active substance
HU208949B (en) 1989-12-22 1994-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 4-trans-/4-isopropyliden-amino/-cyclohexanol
DK0530446T3 (da) 1991-07-05 1998-09-23 Asta Medica Ag Anvendelse af svovlholdige carboxylsyrer til bekæmpelse af pathophysiologisk betingede exitationsforstyrrelser
DE4343592C2 (de) 1993-12-21 1998-04-16 Asta Medica Ag Verwendung von R-(+)-alpha-Liponsäure und dessen Metaboliten in Form der freien Säure oder als Salze oder Ester oder Amide zur Behandlung von Glukosestoffwechselstörungen des zentralen Nervensystems
DE4420102A1 (de) * 1994-06-09 1995-12-14 Asta Medica Ag Arzneimittelkombinationen aus alpha-Liponsäure und herz-kreislaufaktiven Substanzen
DE4447599C2 (de) 1994-11-08 1998-02-26 Asta Medica Ag Verwendung von R,S-(+/-)-alpha-Liponsäure, R-(+)-alpha-Liponsäure, S-(-)-alpha-Liponsäure in reduzierter oder oxidierter Form oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung von Hörstörungen
US6245350B1 (en) 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
ATE194486T1 (de) 1994-12-16 2000-07-15 Warner Lambert Co Verfahren zur einkapselung von tabletten in eine kapsel und feststoff-dosierungsformen erhaltbar durch dieses verfahren
WO1996033704A1 (fr) 1995-04-26 1996-10-31 Taisho Pharmaceutical Co., Ltd. Preparation pour administration orale
HUP9601442A3 (en) 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
DE19806354B4 (de) * 1998-02-10 2004-09-16 Bdd Group Holding Ag Verwendung von α-Liponsäure oder deren physiologisch verträgliche Salze zur Behandlung von LDL-Hypercholesterinämie
IT1311924B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
DE19933148A1 (de) 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette

Also Published As

Publication number Publication date
BR0209732A (pt) 2004-09-14
MXPA03010833A (es) 2004-11-22
US20040127550A1 (en) 2004-07-01
CA2446673A1 (en) 2002-12-05
DE10292279D2 (de) 2004-05-06
AR034336A1 (es) 2004-02-18
JP4245926B2 (ja) 2009-04-02
DK1392285T3 (da) 2005-06-13
CN100435793C (zh) 2008-11-26
HK1063606A1 (en) 2005-01-07
CA2446673C (en) 2010-12-14
RU2285525C2 (ru) 2006-10-20
WO2002096414A1 (de) 2002-12-05
DE50202227D1 (de) 2005-03-17
EP1392285B1 (de) 2005-02-09
JP2004535410A (ja) 2004-11-25
CN1531429A (zh) 2004-09-22
ATE288750T1 (de) 2005-02-15
ES2237683T3 (es) 2005-08-01
US7531567B2 (en) 2009-05-12
RU2003137772A (ru) 2005-05-27
DE10125883A1 (de) 2002-12-12
EP1392285A1 (de) 2004-03-03
PE20030090A1 (es) 2003-04-01

Similar Documents

Publication Publication Date Title
AU2003225160A8 (en) "biosensor for dialysis therapy"
NO20033815L (no) Farmasöytiske salter
IL165480A0 (en) Topical drug delivery using phosphatidylcholine
DE69932040D1 (de) Inhalations medikamentenspender
PT1216225E (pt) Novos derivados de acido aminodicarboxilico com propriedade farmaceuticas
AU2002361453A1 (en) Metered dose inhaler
AU2002337758A1 (en) Wearable continuous renal replacement therapy device
HUP0400988A3 (en) Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
AP2005003346A0 (en) Topical anti-infective formulations
IL159875A0 (en) Zero order controlled drug delivery system
PT1392285E (pt) Medicamento contendo um efector do metabolismo da glutationa em conjunto com acido alfa-lipoico no ambito da terapia de substituicao renal
HUP0600854A2 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
IL150475A0 (en) Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid
IL162509A (en) Use of deoxypeganine for the production of a drug for treating clinical depression
GB2377413B (en) Apparatus for medication dispensing to or topical care for a group of patients
IL152751A0 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
AU2002317683A1 (en) Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
AU2003240169A1 (en) Dermocosmetic treatment by metabolic phospholipids
UA5373S (uk) Упаковка для медичного препарату «мазь «фастин-1»
AU2002349567A1 (en) Neuro musculare developing care
UA5382S (uk) Упаковка для медичного препарату «мазь оксолінова»
IL158881A0 (en) Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
AU2002329270A1 (en) Salicylic acid salts, methods for the production and use thereof as medicaments
UA5182S (uk) Флакон для ліків «лів-52»
GB0105652D0 (en) A rebreathing system to treat the hyperventilating patient